{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:26:09Z","timestamp":1781655969393,"version":"3.54.5"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,11,5]],"date-time":"2015-11-05T00:00:00Z","timestamp":1446681600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Women's Health"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12905-015-0261-7","type":"journal-article","created":{"date-parts":[[2015,11,5]],"date-time":"2015-11-05T13:36:24Z","timestamp":1446730584000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["The costs of offering HPV-testing on self-taken samples to non-attendees of cervical screening in Finland"],"prefix":"10.1186","volume":"15","author":[{"given":"Anni","family":"Virtanen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahti","family":"Anttila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pekka","family":"Nieminen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,11,5]]},"reference":[{"key":"261_CR1","unstructured":"Finnish Cancer Registry Statistics. Finnish Cancer Registry, Statistics. Available online: www.cancerregistry.fi\/statistics Accessed 2014\/10\/24."},{"key":"261_CR2","doi-asserted-by":"publisher","first-page":"2134","DOI":"10.1002\/ijc.27844","volume":"132","author":"S L\u00f6nnberg","year":"2013","unstructured":"L\u00f6nnberg S, Nieminen P, Luostarinen T, Anttila A. Mortality audit of the Finnish cervical cancer screening program. Int J Cancer. 2013;132:2134\u201340. doi: 10.1002\/ijc.27844 .","journal-title":"Int J Cancer"},{"key":"261_CR3","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1158\/1055-9965.EPI-12-0162","volume":"21","author":"S L\u00f6nnberg","year":"2012","unstructured":"L\u00f6nnberg S, Anttila A, Luostarinen T, Nieminen P. Age-specific effectiveness of the Finnish cervical cancer screening programme. Cancer Epidemiol Biomarkers Prev. 2012;21:1354\u201361. doi: 10.1158\/1055-9965.EPI-12-0162 .","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"261_CR4","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1136\/bmj.295.6591.181-a","volume":"295","author":"A Wilson","year":"1987","unstructured":"Wilson A, Leeming A. Cervical cytology screening : a comparison of two call systems. BMJ. 1987;295:181\u20132.","journal-title":"BMJ"},{"key":"261_CR5","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1111\/j.1753-6405.1995.tb00368.x","volume":"19","author":"DA Pritchard","year":"1995","unstructured":"Pritchard DA, Straton JA, Hyndman J. Cervical screening in general practice. Aust J Public Health. 1995;19:167\u201372.","journal-title":"Aust J Public Health"},{"key":"261_CR6","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1177\/030089169808400307","volume":"84","author":"N Segnan","year":"1998","unstructured":"Segnan N, Senore C, Giordano L, Ponti A, Ronco G. Promoting participation in a population screening program for breast and cervical cancer: a randomized trial of different invitation strategies. Tumori. 1998;84:348\u201353.","journal-title":"Tumori"},{"key":"261_CR7","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1093\/intqhc\/11.3.193","volume":"11","author":"RP Hermens","year":"1999","unstructured":"Hermens RP, Hak E, Hulscher ME, Mulder J, Tacken MA, Braspenning JC, et al. Improving population-based cervical cancer screening in general practice: effects of a national strategy. Int J Qual Health Care. 1999;11:193\u2013200.","journal-title":"Int J Qual Health Care"},{"key":"261_CR8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta4140","volume":"4","author":"R Jepson","year":"2000","unstructured":"Jepson R, Clegg A, Forbes C, Lewis R, Sowden A, Kleijnen J. The determinants of screening uptake and interventions for increasing uptake: a systematic review. Health Technol Assess. 2000;4:1\u2013133.","journal-title":"Health Technol Assess"},{"key":"261_CR9","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1158\/1055-9965.346.13.3","volume":"13","author":"S Eaker","year":"2004","unstructured":"Eaker S, Adami HO, Granath F, Wilander E, Sparen P. A large population-based randomized controlled trial to increase attendance at screening for cervical cancer. Cancer Epidemiol Biomarkers Prev. 2004;13:346\u201354.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"261_CR10","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1111\/j.1467-842X.2005.tb00753.x","volume":"29","author":"S Morrell","year":"2005","unstructured":"Morrell S, Taylor R, Zeckendorf S, Niciak A, Wain G, Ross J. How much does a reminder letter increase cervical screening among under-screened women in NSW? Aust N Z J Public Health. 2005;29:78\u201384.","journal-title":"Aust N Z J Public Health"},{"key":"261_CR11","doi-asserted-by":"publisher","unstructured":"Everett T, Bryant A, Griffin MF, Martin-Hirsch PP, Forbes CA, Jepson RG. Interventions targeted at women to encourage the uptake of cervical screening. Cochrane Database Syst Rev 2011:CD002834. doi: 10.1002\/14651858.CD002834.pub2 .","DOI":"10.1002\/14651858.CD002834.pub2"},{"key":"261_CR12","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1158\/1055-9965.EPI-11-0307","volume":"20","author":"A Virtanen","year":"2011","unstructured":"Virtanen A, Nieminen P, Luostarinen T, Anttila A. Self-sample HPV tests as an intervention for nonattendees of cervical cancer screening in Finland: a randomized trial. Cancer Epidemiol Biomarkers Prev. 2011;20:1960\u20139. doi: 10.1158\/1055-9965.EPI-11-0307 .","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"261_CR13","doi-asserted-by":"publisher","first-page":"2681","DOI":"10.1002\/ijc.25581","volume":"128","author":"A Virtanen","year":"2011","unstructured":"Virtanen A, Anttila A, Luostarinen T, Nieminen P. Self-sampling versus reminder letter: effects on cervical cancer screening attendance and coverage in Finland. Int J Cancer. 2011;128:2681\u20137. doi: 10.1002\/ijc.25581 .","journal-title":"Int J Cancer"},{"key":"261_CR14","doi-asserted-by":"publisher","unstructured":"Virtanen A, Anttila A, Luostarinen T, Malila N, Nieminen P. Improving cervical cancer screening attendance in Finland. Int J Cancer 2015:136(6):E677-84. doi: 10.1002\/ijc.29176","DOI":"10.1002\/ijc.29176"},{"key":"261_CR15","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1002\/ijc.27985","volume":"133","author":"G Broberg","year":"2013","unstructured":"Broberg G, Jonasson JM, Ellis J, Gyrd-Hansen D, Anjemark B, Glantz A, et al. Increasing participation in cervical cancer screening: telephone contact with long-term non-attendees in Sweden. Results from RACOMIP, a randomized controlled trial. Int J Cancer. 2013;133:164\u201371. doi: 10.1002\/ijc.27985 .","journal-title":"Int J Cancer"},{"key":"261_CR16","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1177\/096914139500200408","volume":"2","author":"J Bowman","year":"1995","unstructured":"Bowman J, Sanson-fisher R, Boyle C, Pope S, Redman S. A randomised controlled trial to prompt attendance for a Pap smear. J Med Screen. 1995;2:211\u20138. doi: 10.1177\/096914139500200408 .","journal-title":"J Med Screen"},{"key":"261_CR17","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1038\/sj.bjc.6605194","volume":"101","author":"K Sanner","year":"2009","unstructured":"Sanner K, Wikstr\u00f6m I, Strand A, Lindell M, Wilander E. Self-sampling of the vaginal fluid at home combined with high-risk HPV testing. Br J Cancer. 2009;101:871\u20134. doi: 10.1038\/sj.bjc.6605194 .","journal-title":"Br J Cancer"},{"key":"261_CR18","doi-asserted-by":"publisher","first-page":"c1040","DOI":"10.1136\/bmj.c1040","volume":"340","author":"M G\u00f6k","year":"2010","unstructured":"G\u00f6k M, Heideman DAM, van Kemenade FJ, Berkhof J, Rozendaal L, Spruyt JWM, et al. HPV testing on self collected cervicovaginal lavage specimens as screening method for women who do not attend cervical screening: cohort study. BMJ. 2010;340:c1040. doi: 10.1136\/bmj.c1040 .","journal-title":"BMJ"},{"key":"261_CR19","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1038\/bjc.2011.48","volume":"104","author":"A Szarewski","year":"2011","unstructured":"Szarewski A, Cadman L, Mesher D, Austin J, Ashdown-Barr L, Edwards R, et al. HPV self-sampling as an alternative strategy in non-attenders for cervical screening - a randomised controlled trial. Br J Cancer. 2011;104:915\u201320. doi: 10.1038\/bjc.2011.48 .","journal-title":"Br J Cancer"},{"key":"261_CR20","doi-asserted-by":"publisher","first-page":"2681","DOI":"10.1002\/ijc.28283","volume":"133","author":"H Sancho-Garnier","year":"2013","unstructured":"Sancho-Garnier H, Tamalet C, Halfon P, Leandri FX, Le Retraite L, Djoufelkit K, et al. HPV self-sampling or the Pap-smear: a randomized study among cervical screening nonattenders from lower socioeconomic groups in France. Int J Cancer. 2013;133:2681\u20137. doi: 10.1002\/ijc.28283 .","journal-title":"Int J Cancer"},{"key":"261_CR21","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/sj.bjc.6606040","volume":"104","author":"P Giorgi Rossi","year":"2011","unstructured":"Giorgi Rossi P, Marsili LM, Camilloni L, Iossa A, Lattanzi A, Sani C, et al. The effect of self-sampled HPV testing on participation to cervical cancer screening in Italy: a randomised controlled trial (ISRCTN96071600). Br J Cancer. 2011;104:248\u201354. doi: 10.1038\/sj.bjc.6606040 .","journal-title":"Br J Cancer"},{"key":"261_CR22","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.1002\/ijc.28545","volume":"134","author":"G Broberg","year":"2014","unstructured":"Broberg G, Gyrd-Hansen D, Miao Jonasson J, Ryd M-L, Holtenman M, Milsom I, et al. Increasing participation in cervical cancer screening: offering a HPV self-test to long-term non-attendees as part of RACOMIP, a Swedish randomized controlled trial. Int J Cancer. 2014;134:2223\u201330. doi: 10.1002\/ijc.28545 .","journal-title":"Int J Cancer"},{"key":"261_CR23","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1016\/S0959-8049(00)00311-7","volume":"36","author":"A Anttila","year":"2000","unstructured":"Anttila A, Nieminen P. Cervical cancer screening programme in Finland. Eur J Cancer. 2000;36:2209\u201314.","journal-title":"Eur J Cancer"},{"key":"261_CR24","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1002\/ijc.28646","volume":"135","author":"H Salo","year":"2014","unstructured":"Salo H, Nieminen P, Kilpi T, Auranen K, Leino T, V\u00e4nsk\u00e4 S, et al. Divergent coverage, frequency and costs of organised and opportunistic Pap testing in Finland. Int J Cancer. 2014;135:204\u201313. doi: 10.1002\/ijc.28646 .","journal-title":"Int J Cancer"},{"key":"261_CR25","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1002\/ijc.28145","volume":"133","author":"H Salo","year":"2013","unstructured":"Salo H, Leino T, Kilpi T, Auranen K, Tiihonen P, Lehtinen M, et al. The burden and costs of prevention and management of genital disease caused by HPV in women: A population-based registry study in Finland. Int J Cancer. 2013;133:1459\u201369. doi: 10.1002\/ijc.28145 .","journal-title":"Int J Cancer"},{"key":"261_CR26","doi-asserted-by":"publisher","unstructured":"Haguenoer K, Sengchanh S, Gaudy-Graffin C, Boyard J, Fontenay R, Marret H, et al. Vaginal self-sampling is a cost-effective way to increase participation in a cervical cancer screening programme: a randomised trial. Br J Cancer 2014:1\u201310. doi: 10.1038\/bjc.2014.510","DOI":"10.1038\/bjc.2014.510"},{"key":"261_CR27","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1002\/ijc.28838","volume":"135","author":"EA Burger","year":"2014","unstructured":"Burger EA, Kim JJ. The value of improving failures within a cervical cancer screening program: An example from Norway. Int J Cancer. 2014;135:1931\u20139. doi: 10.1002\/ijc.28838 .","journal-title":"Int J Cancer"},{"key":"261_CR28","doi-asserted-by":"publisher","unstructured":"Rozemeijer K, de Kok IMCM, Naber SK, van Kemenade FJ, Penning C, van Rosmalen J, et al. Offering self-sampling to non-attendees of organized primary HPV screening: When do harms outweigh the benefits? Cancer Epidemiol Biomarkers Prev 2014. doi: 10.1158\/1055-9965.EPI-14-0998","DOI":"10.1158\/1055-9965.EPI-14-0998"},{"key":"261_CR29","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1002\/ijc.22484","volume":"120","author":"AG Bais","year":"2007","unstructured":"Bais AG, van Kemenade FJ, Berkhof J, Verheijen RH, Snijders PJ, Voorhorst F, et al. Human papillomavirus testing on self-sampled cervicovaginal brushes: an effective alternative to protect nonresponders in cervical screening programs. Int J Cancer. 2007;120:1505\u201310.","journal-title":"Int J Cancer"},{"issue":"3","key":"261_CR30","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.ygyno.2014.09.019","volume":"135","author":"A Virtanen","year":"2014","unstructured":"Virtanen A, Nieminen P, Niironen M, Luostarinen T, Anttila A. Self-sampling experiences among non-attendees to cervical screening. Gynecol Oncol. 2014;135(3):487\u201394. doi: 10.1016\/j.ygyno.2014.09.019 .","journal-title":"Gynecol Oncol"},{"key":"261_CR31","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/S1470-2045(14)70019-1","volume":"15","author":"VMJ Verhoef","year":"2014","unstructured":"Verhoef VMJ, Bosgraaf RP, Van Kemenade FJ, Rozendaal L, Heideman DA M, Hesselink AT, et al. Triage by methylation-marker testing versus cytology in women who test HPV-positive on self-collected cervicovaginal specimens (PROHTECT-3): a randomised controlled non-inferiority trial. Lancet Oncol. 2014;15:315\u201322.","journal-title":"Lancet Oncol"},{"key":"261_CR32","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/S1470-2045(13)70570-9","volume":"15","author":"M Arbyn","year":"2014","unstructured":"Arbyn M, Verdoodt F, Snijders PJF, Verhoef VMJ, Suonio E, Dillner L, et al. Accuracy of human papillomavirus testing on self-collected versus clinician-collected samples: a meta-analysis. Lancet Oncol. 2014;15:172\u201383. doi: 10.1016\/S1470-2045(13)70570-9 .","journal-title":"Lancet Oncol"}],"container-title":["BMC Women's Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-015-0261-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12905-015-0261-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-015-0261-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,15]],"date-time":"2023-08-15T19:15:01Z","timestamp":1692126901000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcwomenshealth.biomedcentral.com\/articles\/10.1186\/s12905-015-0261-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,5]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["261"],"URL":"https:\/\/doi.org\/10.1186\/s12905-015-0261-7","relation":{},"ISSN":["1472-6874"],"issn-type":[{"value":"1472-6874","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,5]]},"article-number":"99"}}